DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Antibiotic Resistant Helicobacter Pylori in Rajavithi Hospital

Information source: Rajavithi Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Dyspepsia

Intervention: gastroscopic examination (Procedure)

Phase: Phase 3

Status: Recruiting

Sponsored by: Rajavithi Hospital

Official(s) and/or principal investigator(s):
Piyathida Harnsoomboon, MD, Principal Investigator, Affiliation: Rajavithi Hospital

Summary

Peptic ulcer disease is the most common gastrointestinal disease. Antibiotic resistant Helicobacter pylori is a major problem worldwide. The gold standard for Helicobacter pylori eradication is composed of Proton-pump inhibitor/Ranitidine bismuth citrate + Amoxycillin + Metronidazole /Clarithromycin. In Thailand, clarithromycin resistant strains increased and led to treatment failure. Data on file at Rajavithi Hospital showed that metronidazole resistant H. pylori was about 50% and Clarithromycin resistant strains accounted for 8%. This molecular genetic study will be performed in patients presenting with dyspepsia, who had an indication for gastroscopic examination, to explore the incidence of antibiotic resistant Helicobacter pylori in Rajavithi Hospital, Thailand.

Clinical Details

Official title: Antibiotic Resistance Helicobacter Pylori and Clarithromycin Resistance Mutation in Helicobacter Pylori in Rajavithi Hospital

Study design: Case Control, Prospective

Primary outcome: Incidence of H. pylori Clarithromycin resistance gene

Secondary outcome: Characteristic of H. pylori clarithromycin resistant gene mutation

Detailed description: Genetic and Biomolecular factors determining clarithromycin resistance will be characterized.

Eligibility

Minimum age: 15 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- male or female with dyspepsia

- age > 15 years

- fulfil indication for gastroscopic examination

- able to give informed consent

Exclusion Criteria:

- contraindication for gastroscopic examination and biopsy

Locations and Contacts

Rajavithi Hospital, Ratchathewi, Bangkok 10400, Thailand; Recruiting
Piyathida Harnsomboonrana, M.D., Phone: 6618423854, Email: pboontee@yahoo.com
Additional Information

Starting date: June 2006
Ending date: December 2008
Last updated: August 2, 2008

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009